A Phase I Multi-Cohort Trial of Pembrolizumab (MK-3475) in Combination with Backbone Treatments for Subjects with Multiple Myeloma

Type of Cancer
Multiple Myeloma

Site
Freehold, Howell, Little Silver

Sponsor
MERCK

Protocol Number
MERCK-3475-023

To Learn More Call
201-510-0910